SK pharmteco
Peri Morris is an accomplished professional in the field of biotechnology and manufacturing, currently serving as the Director of Business Operations at SK pharmteco and the Center for Breakthrough Medicines, with previous experience in strategic operations and manufacturing at Lonza and other organizations. Peri has held various roles, including Senior Manager of Strategic Operations and Manufacturing Project Manager, contributing to process improvement and operational efficiency in CGT manufacturing. Educational credentials include a Master’s Degree in Biotechnology from Texas A&M University and a Bachelor of Science in Biology from South Carolina State University.
This person is not in any offices
SK pharmteco
Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.